Therapeutic Digest


August 15, 2020

There is no question that medicine and society benefited mightily from the Golden Age of Cardiology, from the 1970s onward, when age-adjusted death rates plummeted by as much as 70% in some western countries. Yet, cardiovascular disease remains one of the costliest disease in the U.S., with direct medical costs of $555 billion in 2016. By 2035, that figure is expected to double to $1.1 trillion. While the prevalence of cardiovascular disease is certainly a major contributor, so, too, is the high use of technology in the field, including imaging and devices.

Post a Comment

You must be logged in to post a Comment.